Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

IDEXX Laboratories Q1 2024 Adj EPS $2.81 Beats $2.67 Estimate, Sales $964.00M Miss $966.13M Estimate

Author: Benzinga Newsdesk | May 01, 2024 06:31am
IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $2.81 per share which beat the analyst consensus estimate of $2.67 by 5.24 percent. The company reported quarterly sales of $964.00 million which missed the analyst consensus estimate of $966.13 million by 0.22 percent. This is a 7.09 percent increase over sales of $900.20 million the same period last year.

Posted In: IDXX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist